Crossref
FDA Approves New Generic Inhaler for Asthma Treatment
JAMA · 21.04.2026 · 335 (15) · 1291
DOI: 10.1001/jama.2026.1024 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 21.04.2026. Verfasst von Samantha Anderer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Anderer, S. (2026). FDA Approves New Generic Inhaler for Asthma Treatment. JAMA, 335(15), 1291. https://doi.org/10.1001/jama.2026.1024
Vancouver
Anderer S. FDA Approves New Generic Inhaler for Asthma Treatment. JAMA. 2026;335(15):1291. doi:10.1001/jama.2026.1024
BibTeX
@article{Anderer2026,
author = {Anderer, Samantha},
title = {FDA Approves New Generic Inhaler for Asthma Treatment},
journal = {JAMA},
year = {2026},
volume = {335},
number = {15},
pages = {1291},
doi = {10.1001/jama.2026.1024}
}
EUVIMED